Blood Coagulation Factors Concept

subject area of

• A 23bp Insertion in the Endothelial Protein C Receptor (EPCR) Gene Impairs EPCR Function  Academic Article
• A comparison of the quantitative ristocetin von willebrand factor assay by using fresh and fixed platelets  Academic Article
• A novel treatment for lupus nephritis: lignan precursor derived from flax  Academic Article
• A survey of patients with haemophilia to understand how they track product used at home  Academic Article
• Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus  Academic Article
• Acute Hepatic Necrosis and Ischemic Limb Necrosis  Academic Article
• Acute Thrombocytopenia and Thrombosis.  Academic Article
• Altered preoperative coagulation and fibrinolysis are associated with myocardial injury after non-cardiac surgery  Academic Article
• An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.  Academic Article
• An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect  Academic Article
• Analysis of Inhibition Rate Enhancement by Covalent Linkage of Antithrombin to Heparin as a Potential Predictor of Reaction Mechanism  Academic Article
• Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis  Academic Article
• Anticoagulants in pregnancy: A review of indications and complications  Academic Article
• Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin  Academic Article
• Bile acids and coagulation factors  Academic Article
• Bivalirudin, thrombin and platelets: clinical implications and future directions.  Academic Article
• Bleeding and antidotes in new oral anticoagulants  Academic Article
• Bleeding disorders in neonates  Academic Article
• C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population  Academic Article
• Can evidence harm? Certainly not hemophilia treatment and community  Academic Article
• Challenging the 30‐min rule for thawed plasma  Academic Article
• Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing  Academic Article
• Chemistry, Measurement, and Clinical Significance of Platelet Specific Proteins  Academic Article
• Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.  Academic Article
• Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes  Academic Article
• Clotting factor concentrate switching and inhibitor development in hemophilia A  Academic Article
• Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B  Academic Article
• Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B  Academic Article
• Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B  Academic Article
• Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B  Academic Article
• Coagulation Disorders and Blood Product Use in Patients Undergoing Thoracoabdominal Aortic Aneurysm Repair  Academic Article
• Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass  Academic Article
• Coagulation factor concentrates by continuous infusion  Academic Article
• Coagulopathy in a patient with nephrotic syndrome  Academic Article
• Colloid Transfusion, Natural Anticoagulant Depletion, and Symmetric Peripheral Gangrene  Academic Article
• Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”  Academic Article
• Comparative effects of heparin and LMW heparin on hemostasis  Conference Paper
• Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers  Academic Article
• Continuous Infusion of Factor Concentrates: Review of Use in Hemophilia A and Demonstration of Safety and Efficacy in Hemophilia B  Conference Paper
• Continuous infusion  Conference Paper
• Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time  Academic Article
• Coping Style in Relation to the Consumption of Factor Concentrate in HIV-Infected Hemophiliacs during the Years after Their Infection Became Known  Academic Article
• Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study  Academic Article
• Current anticoagulant therapy—unmet clinical needs  Conference Paper
• DDAVP—The Multipotent Drug in Patients With Coagulopathies  Academic Article
• Detection of a Platelet-Agglutinating Factor in Thrombotic Thrombocytopenic Purpura  Academic Article
• Developing a tracking system for coagulation factor concentrates in southern Ontario  Academic Article
• Development of the human coagulation system in the full-term infant  Academic Article
• Development of the human coagulation system in the healthy premature infant  Academic Article
• Diagnosis and treatment of intracranial hemorrhage in children with hemophilia  Academic Article
• Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding  Academic Article
• EFFECT OF SERA ON THROMBIN ACTIVATION RATE CONSTANTS: A ONE-STAGE ASSAY OF THE EXTRINSIC SYSTEM  Academic Article
• EPIDEMIOLOGY AND PATHOGENESIS OF VENOUS THROMBOSIS  Academic Article
• Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines  Academic Article
• Effect of RA233 on Platelet Function In Vitro  Academic Article
• Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.  Academic Article
• Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.  Academic Article
• Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events  Academic Article
• Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway  Academic Article
• Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation  Academic Article
• Emicizumab state‐of‐the‐art update  Academic Article
• Endogenous protein C activation in patients with severe sepsis  Academic Article
• Epidemiology and pathogenesis of venous thrombosis  Academic Article
• EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis  Academic Article
• Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study  Academic Article
• Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding  Academic Article
• Exchange of albumin adsorbed on polymer surfaces.  Academic Article
• Factors XI and XII are low in subjects with liver disease  Academic Article
• Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia  Academic Article
• First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data from CHARMS , the Canadian Hemophilia Assessment and Resource Management System  Academic Article
• Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding  Academic Article
• Fusion to Human Serum Albumin Extends the Circulatory Half-Life and Duration of Antithrombotic Action of the Kunitz Protease Inhibitor Domain of Protease Nexin 2  Academic Article
• Global data and haemophilia care trends: commentary  Academic Article
• Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors  Academic Article
• Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.  Academic Article
• Haemophilia care – past, present and future from a patient perspective  Academic Article
• Haemophilia prophylaxis: how can we justify the costs?  Academic Article
• Haemorrhagic and Thromboembolic Complications versus Intensity of Treatment of Venous Thromboembolism with Oral Anticoagulants  Academic Article
• Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants.  Academic Article
• Handheld computers and paper diaries for documenting the use of factor concentrates used in haemophilia home therapy: a qualitative study  Academic Article
• Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy  Academic Article
• Hemostasis and atherosclerosis.  Academic Article
• Heparin/Heparan Sulfate (HP/HS) Interacting Protein (HIP) Supports Cell Attachment and Selective, High Affinity Binding of HP/HS  Academic Article
• Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs  Academic Article
• How I treat target-specific oral anticoagulant–associated bleeding  Academic Article
• How can we reverse bleeding in patients on direct oral anticoagulants?  Academic Article
• Hypercoagulability.  Academic Article
• Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients  Academic Article
• IMMUNOMODULATORY EFFECT OF THE TREATMENT OF GRAVES’DISEASE ON ANTIGEN-SPECIFIC MONOCYTE PROCOAGULANT ACTIVITY PRODUCTION  Academic Article
• Identification of proteins adsorbed to hemodialyser membranes from heparinized plasma  Academic Article
• Identification of the Protein C/Activated Protein C Binding Sites on the Endothelial Cell Protein C Receptor  Academic Article
• Impact of Arterial Procedures on Coagulation and Fibrinolysis – A Pilot Study  Academic Article
• Impaired Fibrinolytic Activity Is Present in Children with Dyslipidemias  Academic Article
• Infection-Induced Thrombocytopenia  Academic Article
• Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis  Academic Article
• Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin  Academic Article
• Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors  Academic Article
• Intraglomerular localization of platelet related antigens, platelet factor 4 and beta-thromboglobulin in glomerulonephritis.  Academic Article
• Joint WFH‐ISTH session: issues in clinical trial design  Academic Article
• Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics  Academic Article
• Laboratory abnormalities in thrombotic thrombocytopenic purpura  Academic Article
• Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group.  Academic Article
• Management of bleeding with oral anticoagulants in patients with atrial fibrillation  Academic Article
• Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis  Academic Article
• Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report  Academic Article
• Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study  Academic Article
• Massive transfusion  Academic Article
• Maturation of the hemostatic system during childhood  Academic Article
• Measurement of platelet release substances in glomerulonephritis: A comparison of beta-thromboglobulin (β-TG), platelet factor 4 (PF4) and serotonin assays  Academic Article
• Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function  Academic Article
• Monitoring and reversal of direct oral anticoagulants  Academic Article
• Monitoring the anticoagulant effect after a massive rivaroxaban overdose  Academic Article
• Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.  Academic Article
• More on: are randomized clinical trials the only truth? Not always  Academic Article
• Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate  Academic Article
• New Concepts in Coagulation  Academic Article
• New anticoagulant drugs.  Academic Article
• New anticoagulants  Conference Paper
• New developments in laboratory diagnosis and monitoring  Academic Article
• New oral anticoagulants: A view from the laboratory  Academic Article
• Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel  Academic Article
• Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial  Academic Article
• Optimal reversal of vitamin K antagonists  Academic Article
• Oral surgery in patients with hereditary bleeding disorders  Academic Article
• Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials  Academic Article
• Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care  Academic Article
• Orthotopic liver transplantation in a patient with combined hemophilia A and B  Academic Article
• Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes  Academic Article
• Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study  Academic Article
• Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH  Academic Article
• Placental Barrier to Coagulation Factors: Its Relevance to the Coagulation Defect at Birth and to Haemorrhage in the Newborn  Academic Article
• Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review  Academic Article
• Plasma-derived biological medicines used to promote haemostasis  Academic Article
• Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation  Academic Article
• Platelet-Aggregating Factor in Thrombotic Thrombocytopenic Purpura  Academic Article
• Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants  Academic Article
• Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung  Academic Article
• Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized  Academic Article
• Prolonged hemorrhagic shock does not impair regeneration of plasma coagulant masses in the rabbit  Academic Article
• Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature  Academic Article
• Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma  Academic Article
• Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study  Academic Article
• Prothrombin Complex Concentrates for Intracranial Hemorrhage on Factor Xa Inhibitors  Academic Article
• Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non–vitamin K Anticoagulant Reversal  Academic Article
• Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation  Academic Article
• Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study  Academic Article
• Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis  Academic Article
• Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy  Academic Article
• Rapid reversal of haematoma expansion associated with vitamin K antagonists  Academic Article
• Rare inherited coagulation and fibrinolytic defects that challenge diagnostic laboratories  Academic Article
• Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent  Academic Article
• Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors  Academic Article
• Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura  Academic Article
• Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies  Academic Article
• Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study  Academic Article
• Reversing Anticoagulant Therapy  Academic Article
• Reversing anticoagulants both old and new.  Academic Article
• Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers  Academic Article
• Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists  Academic Article
• Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity test  Academic Article
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia  Academic Article
• Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders  Academic Article
• Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis?  Academic Article
• Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw  Academic Article
• Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose  Academic Article
• Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates  Academic Article
• The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates  Academic Article
• The Coagulation System in Humans  Academic Article
• The fibrinolytic system in newborns and children.  Academic Article
• The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.  Academic Article
• The role of leukocytes in thrombosis  Academic Article
• The status of new anticoagulants  Academic Article
• Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin  Academic Article
• Thrombin Regulation in Mother and Fetus During Pregnancy  Academic Article
• Thrombin activation rate constant: One-stage chromogenic assay for the extrinsic system  Academic Article
• Thrombin and Antithrombotics  Academic Article
• Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes  Academic Article
• Thrombin generationin vitroin the presence of by-passing agents in siblings with severe haemophilia A  Academic Article
• Thrombin structure and function  Academic Article
• Thromboepidemiology: Identifying patients with heritable risk for thrombin-mediated thromboembolic events  Academic Article
• Thrombosis in children with acute lymphoblastic leukemia  Academic Article
• Thrombotic and Hemorrhagic Complications in Children With the Lupus Anticoagulant  Academic Article
• Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme  Academic Article
• Unraveling von Willebrand factor deficiency  Academic Article
• Using pharmacokinetics to individualize hemophilia therapy  Academic Article
• Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis  Academic Article
• Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome  Academic Article
• Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method  Academic Article
• [New preparations for coagulation disorders].  Academic Article